These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 10124249)
1. OTA report assails profits on new drugs. Wagner L; Weissenstein E Mod Healthc; 1993 Mar; 23(9):3. PubMed ID: 10124249 [No Abstract] [Full Text] [Related]
2. OTA takes closer look at cost of drugs. Blankenau R Hospitals; 1993 Apr; 67(7):48-9. PubMed ID: 8458628 [No Abstract] [Full Text] [Related]
3. Costing drug development. Nat Rev Drug Discov; 2003 Apr; 2(4):247. PubMed ID: 12680358 [No Abstract] [Full Text] [Related]
4. New estimates of drug development costs. Frank RG J Health Econ; 2003 Mar; 22(2):325-30. PubMed ID: 12606149 [No Abstract] [Full Text] [Related]
5. [Health care in the USA depends more and more on drug industry]. Werkö L Lakartidningen; 2004 Sep; 101(38):2915-7. PubMed ID: 15485176 [No Abstract] [Full Text] [Related]
6. [Drug development costs are overstated by the industry]. Jeppsson A Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545 [No Abstract] [Full Text] [Related]
7. [Does the public sector have an independent research role in the development of drugs?]. Poulsen HE; Grønlykke TB Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828 [TBL] [Abstract][Full Text] [Related]
8. Drug costs: research and development costs: the great illusion. Prescrire Int; 2004 Feb; 13(69):32-6. PubMed ID: 15055226 [TBL] [Abstract][Full Text] [Related]
9. Perspectives. CMS and Wall Street report... Med Health; 2003 Jan; 57(4):7-8. PubMed ID: 12602066 [No Abstract] [Full Text] [Related]
10. The right pill for growth. The high cost of developing blockbuster drugs forces big makers into bigger mergers. Fischer JS US News World Rep; 1999 Nov; 127(19):56. PubMed ID: 10623304 [No Abstract] [Full Text] [Related]
11. The price of innovation: new estimates of drug development costs. DiMasi JA; Hansen RW; Grabowski HG J Health Econ; 2003 Mar; 22(2):151-85. PubMed ID: 12606142 [TBL] [Abstract][Full Text] [Related]
12. Returns to R&D on new drug introductions in the 1980s. Grabowski HG; Vernon JM J Health Econ; 1994 Dec; 13(4):383-406. PubMed ID: 10140531 [TBL] [Abstract][Full Text] [Related]
13. Why drugs cost so much. Noonan D Newsweek; 2000 Sep; 136(13):22-30. PubMed ID: 11183315 [No Abstract] [Full Text] [Related]
14. Pharmaceutical research: cost savings through innovation. Cohen KR; Levy RA AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463 [No Abstract] [Full Text] [Related]
15. Clinton's breakthrough drug committee: will it stifle new drug development? Gatty B Hosp Formul; 1993 Nov; 28(11):946, 945. PubMed ID: 10130236 [No Abstract] [Full Text] [Related]
16. Opinion: development of new drugs is still a risky business. Franks B N J Med; 2002; 99(1-2):60, 59. PubMed ID: 15326736 [No Abstract] [Full Text] [Related]
17. Health care accounting: half-truths and sleight-of-hand. Gottlieb S Cost Qual Q J; 1999 Jun; 5(2):28-30. PubMed ID: 10539009 [No Abstract] [Full Text] [Related]
18. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices. Pinzone JD J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775 [No Abstract] [Full Text] [Related]
19. Why these biotechs are as hot as net stocks. Wall Street's betting big on a genetic technology that burned it badly before. Monoclonal antibodies still don't cure cancer--but this time they may actually pay off. McLean B Fortune; 2000 Jan; 141(1):132-4, 135. PubMed ID: 10788044 [No Abstract] [Full Text] [Related]
20. Drug discovery. Kennedy D Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461 [No Abstract] [Full Text] [Related] [Next] [New Search]